IL Science Statistics
Total Valuation
IL Science has a market cap or net worth of KRW 74.64 billion. The enterprise value is 157.69 billion.
Market Cap | 74.64B |
Enterprise Value | 157.69B |
Important Dates
The last earnings date was Friday, March 21, 2025.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IL Science has 27.04 million shares outstanding. The number of shares has increased by 7.89% in one year.
Current Share Class | n/a |
Shares Outstanding | 27.04M |
Shares Change (YoY) | +7.89% |
Shares Change (QoQ) | -4.68% |
Owned by Insiders (%) | 27.43% |
Owned by Institutions (%) | n/a |
Float | 19.35M |
Valuation Ratios
The trailing PE ratio is 172.50.
PE Ratio | 172.50 |
Forward PE | n/a |
PS Ratio | 0.89 |
PB Ratio | 6.24 |
P/TBV Ratio | 19.31 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.37, with an EV/FCF ratio of -8.07.
EV / Earnings | 365.25 |
EV / Sales | 1.89 |
EV / EBITDA | 16.37 |
EV / EBIT | 32.52 |
EV / FCF | -8.07 |
Financial Position
The company has a current ratio of 0.50, with a Debt / Equity ratio of 4.87.
Current Ratio | 0.50 |
Quick Ratio | 0.30 |
Debt / Equity | 4.87 |
Debt / EBITDA | 8.98 |
Debt / FCF | -4.43 |
Interest Coverage | 0.66 |
Financial Efficiency
Return on equity (ROE) is 5.58% and return on invested capital (ROIC) is 3.73%.
Return on Equity (ROE) | 5.58% |
Return on Assets (ROA) | 2.79% |
Return on Invested Capital (ROIC) | 3.73% |
Return on Capital Employed (ROCE) | 13.99% |
Revenue Per Employee | 1.55B |
Profits Per Employee | 8.00M |
Employee Count | 54 |
Asset Turnover | 0.77 |
Inventory Turnover | 8.53 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.18% in the last 52 weeks. The beta is 1.31, so IL Science's price volatility has been higher than the market average.
Beta (5Y) | 1.31 |
52-Week Price Change | +0.18% |
50-Day Moving Average | 2,887.10 |
200-Day Moving Average | 2,991.40 |
Relative Strength Index (RSI) | 39.87 |
Average Volume (20 Days) | 167,932 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IL Science had revenue of KRW 83.50 billion and earned 431.73 million in profits. Earnings per share was 16.00.
Revenue | 83.50B |
Gross Profit | 18.29B |
Operating Income | 4.86B |
Pretax Income | 1.07B |
Net Income | 431.73M |
EBITDA | 9.65B |
EBIT | 4.86B |
Earnings Per Share (EPS) | 16.00 |
Balance Sheet
The company has 9.37 billion in cash and 86.61 billion in debt, giving a net cash position of -77.25 billion or -2,856.50 per share.
Cash & Cash Equivalents | 9.37B |
Total Debt | 86.61B |
Net Cash | -77.25B |
Net Cash Per Share | -2,856.50 |
Equity (Book Value) | 17.77B |
Book Value Per Share | 442.32 |
Working Capital | -51.94B |
Cash Flow
In the last 12 months, operating cash flow was -3.98 billion and capital expenditures -15.55 billion, giving a free cash flow of -19.53 billion.
Operating Cash Flow | -3.98B |
Capital Expenditures | -15.55B |
Free Cash Flow | -19.53B |
FCF Per Share | -722.17 |
Margins
Gross margin is 21.91%, with operating and profit margins of 5.83% and 0.52%.
Gross Margin | 21.91% |
Operating Margin | 5.83% |
Pretax Margin | 1.28% |
Profit Margin | 0.52% |
EBITDA Margin | 11.55% |
EBIT Margin | 5.83% |
FCF Margin | n/a |
Dividends & Yields
IL Science does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 86.86% |
Buyback Yield | -7.89% |
Shareholder Yield | -7.89% |
Earnings Yield | 0.58% |
FCF Yield | -26.17% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
IL Science has an Altman Z-Score of 0.42. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.42 |
Piotroski F-Score | n/a |